Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Cefuroxime in Obese Patients
NCT03141476Phase 4Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Mar 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefuroxime in surgical site infection (SSI) (3 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoints: Serum level of Cefuroxime and Tissue level of Cefuroxime. Started Mar 2017; status: completed.
02
Drugs
cefuroxime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03141476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03141476.